Israeli doctors want to stop European patent for genetic test

BMJ 2005; 331 doi: (Published 30 June 2005) Cite this as: BMJ 2005;331:8

This article has a correction. Please see:

  1. Judy Siegel-Itzkovich
  1. Jerusalem

    Israeli oncologists and geneticists are trying to prevent the European Patent Office from granting a patent to a US company for a genetic test for the BRCA1 mutation, on the grounds that it may be racist. The mutation is responsible for a high risk of breast and ovarian cancer in Jewish women of Ashkenazi (European) origin. The hearing was scheduled for Wednesday 29 June in Munich.

    Registering a patent for a genetic test that identifies a mutation typical only of Jews …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription